Navigation Links
ACPM concludes insufficient evidence to recommend routine prostate cancer screening

Washington, D.C. - The American College of Preventive Medicine (ACPM) has found there is insufficient evidence to recommend for or against routine population prostate screening with digital rectal examination (DRE) or measurement of the serum tumor marker, prostatespecific antigen (PSA). ACPM advises that clinicians caring for men, especially African-American men and those with a family history, should provide information about the potential benefits and harms of screening and limits of current evidence to allow for them to make an informed decision about screening.

According to Dr. Lionel Lim, the lead author of ACPMs recommendation, Patient and clinician discussion about screening is important, however, a man should ultimately be allowed to make his own decision about screening while taking into consideration personal preferences and life expectancy. If the patient prefers to defer to the clinician or is unable to make a decision regarding screening, then testing should not be offered as long as the patient understands the associated benefits, potential limitations, and adverse effects.

Prostate cancer is the leading type of cancer among U.S. men, and the second leading cause of cancer deaths. While prostate cancer incidence increases with age, and men with a family history of prostate cancer and African-American men are at higher risk of both developing and dying from prostate cancer, there are both risks and benefits associated with prostate screening and further studies are needed to establish the efficacy and optimal age at which prostate cancer screening should be initiated in these high-risk population groups.

According to Dr. Michael Parkinson, President of ACPM, Prostate cancer remains a significant concern among U.S. men today. ACPM will continue to review emerging evidence to determine and communicate the most effective methods to detect and prevent the disease.


Contact: Michele Surricchio
American College of Preventive Medicine

Page: 1

Related medicine news :

1. Global Summit on AIDS and the Church Begins Today and Concludes With Youth Summit on World AIDS Day:
2. Neuromed Concludes a Special Protocol Assessment (SPA) with FDA for a Pivotal Phase 3 Study on NMED-1077
3. Hooper Holmes Concludes Sale of Medicals Direct
4. USA TODAY Concludes Spirit of the USA Charity Program as Part of Newspapers 25th Anniversary Celebration
5. Americans Knowledge of Fats Growing But Still Insufficient
6. Evidence found for genes that affect risk of developing Alzheimers disease
7. More evidence suggests diabetes drug may be dangerous
8. Evidence links anemia drugs with leukemic transformation in patients with primary myelofibrosis
9. Evidence of TB Found in 500,000-Year-Old Fossil
10. Diet and cancer prevention: New evidence for the protective effects of fruits and veggies
11. Wiley-Blackwell and U. of Penn Health Systems Center for Evidence-Based Practice launch InfoPOEMs
Post Your Comments:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... 23, 2016  Experian Health, the healthcare ... the patient payment and care experience, today ... products and services that will enhance the ... offerings. These award-winning solutions will enable healthcare ... compliant in an ever-changing environment and redefine ...
Breaking Medicine Technology: